Trial · NCT06643871
Registered outcomes34
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 34 of 34
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Systolic blood pressure | at enrollment and at 15 weeks | Systolic blood pressure in mmHg |
| Secondary | diastolic blood pressure | at enrollment and at 15 weeks | diastolic blood pressure in mmHg |
| Secondary | Quality of life as assessed by WHO-QOL-BREF | at enrollment and at 15 weeks | Total Score at WHO-QOL-BREF (World Health Organization-Quality Of Life) questionnaire |
| Secondary | Psychotic symptomes as measured with the PANSS | at the enrollment and at 15 weeks | Psychotic symptomes measured with the PANSS (Positive and negative symptomes scale). We will measure three outcomes : * Positive symptomes : total score at the positive symptomes subscale of the PANSS * Negative symptomes : total score at the positive symptomes subscale of the PANSS * General symptomes : total score at the general symptomes subscale of the PANSS |
| Secondary | Memory - Verbal Learning | at enrollment and at 15 weeks | Total score at California Verbal Learning Test (CVLT) |
| Secondary | Executive functions Verbal fluencies | at the enrollment and at 15 weeks | Total score at verbal fluencies task |
| Secondary | Acceptibility rate of the DYNAMO-PSY program | From enrollment to the end of the program at 20 weeks | We will calculate the acceptibility rate as followed : Number of patients included / number of eligible patients |
| Secondary | Compliance of participants to the DYNAMO-PSY program | From enrollment to the end of the program at 15 weeks | For each participants, we will measure how many sessions have been completed. The compliance rate will be measured as followed : Number of sessions completed by the participant / 20 (number of planned sessions) |
| Secondary | Negative psychotic symptoms as measured by SNS | at enrollment and at 15 weeks | Total score at self evaluation of negative symptoms scale (autoquestionnaire). |
| Secondary | Memory : Number memory | at the enrollment and at 15 weeks | Score at number memory task |
| Secondary | Executive functions : Planification | at the enrollment and at 15 weeks | Score at the french test -test des comissions- |
| Secondary | Depression symptomes as measured with HAD-D | at enrollment and at 15 weeks | Score at the -depression- subscale of the HAD scale (autoquestionnaire) |
| Secondary | Mean duration of the program | at the first and at the last session of the DYNAMO-PSY program | For each participants that completed the DYNAMO-PSY program, we will measure time (in days) between the first and the last session (ie the 20th) of the DYNAMOPSY program. We will calculate the mean duration of the program among participants that completed the program. |
| Secondary | Anxiety symptoms as measured by HAD-A | at enrollment and at 15 weeks | Score at anxiety subscale of Hospital anxiety and depression scale (HAD-A) (autoquestionnaire) |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06643871/registered?page=2